药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sulfacytine
Phenyl aminosalicylate
Phenyl aminosalicylate may increase the hypoglycemic activities of Canagliflozin.
Sulfacytine
Dersalazine
Dersalazine may increase the hypoglycemic activities of Canagliflozin.
Sulfacytine
Ubidecarenone
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Canagliflozin.
Sulfacytine
Levomilnacipran
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Canagliflozin.
Sulfacytine
Indalpine
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Canagliflozin.
Sulfacytine
Dapoxetine
The risk or severity of hypoglycemia can be increased when Dapoxetine is combined with Canagliflozin.
Sulfacytine
Clinafloxacin
The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Canagliflozin.
Sulfacytine
Cibenzoline
The risk or severity of hypoglycemia can be increased when Cibenzoline is combined with Canagliflozin.
Sulfacytine
Alaproclate
The risk or severity of hypoglycemia can be increased when Alaproclate is combined with Canagliflozin.
Sulfacytine
Ritanserin
The risk or severity of hypoglycemia can be increased when Ritanserin is combined with Canagliflozin.
Sulfacytine
Oxymetholone
Oxymetholone may increase the hypoglycemic activities of Canagliflozin.
Sulfacytine
Mesterolone
Mesterolone may increase the hypoglycemic activities of Canagliflozin.
Sulfacytine
Nandrolone
Nandrolone may increase the hypoglycemic activities of Canagliflozin.
Sulfacytine
GLPG-0492
GLPG-0492 may increase the hypoglycemic activities of Canagliflozin.
Sulfacytine
Nandrolone decanoate
Nandrolone decanoate may increase the hypoglycemic activities of Canagliflozin.
Sulfacytine
Stanozolol
Stanozolol may increase the hypoglycemic activities of Canagliflozin.
Sulfacytine
Fosamprenavir
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Fosamprenavir.
Sulfacytine
Teprotumumab
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Teprotumumab.
Sulfacytine
Lurasidone
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Lurasidone.
Sulfacytine
Brexpiprazole
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Brexpiprazole.